tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market

Cytokinetics (CYTK) Income Statement

Compare
1,026 Followers

Cytokinetics Income Statement

Last quarter (Q4 2024), Cytokinetics's total revenue was $16.93M, an increase of 912.38% from the same quarter last year. In Q4, Cytokinetics's net income was $-150.02M. See Cytokinetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.47M$ 7.53M$ 94.59M$ 70.43M$ 55.83M
Gross Profit
$ 18.47M$ -322.59M$ -146.22M$ -89.51M$ -41.12M
Operating Expenses
$ 554.72M$ 173.61M$ 177.98M$ 96.80M$ 52.82M
Depreciation and Amortization
$ 9.53M$ 11.89M$ 8.40M$ 9.64M$ 1.83M
EBITDA
$ -493.48M$ -456.68M$ -329.40M$ -176.34M$ -86.78M
Operating Income
$ -536.25M$ -496.20M$ -324.20M$ -186.31M$ -93.94M
Other Income/Expenses
$ -53.28M$ -30.04M$ -64.75M$ -29.00M$ -33.35M
Pretax Income
$ -589.53M$ -526.24M$ -388.95M$ -215.31M$ -127.29M
Net Income
$ -589.53M$ -526.24M$ -402.55M$ -242.37M$ -164.13M
Per Share Metrics
Basic EPS
$ -5.26$ -5.45$ -4.48$ -3.15$ -2.54
Diluted EPS
$ -5.26$ -5.45$ -4.48$ -3.15$ -2.54
Weighted Average Shares Outstanding
111.98M 96.52M 89.83M 76.89M 64.52M
Weighted Average Shares Outstanding (Diluted)
111.98M 96.52M 89.83M 76.89M 64.52M
Currency in USD

Cytokinetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis